Norman G. Anderson
Research Subjects
Norman G. Anderson has a total of 12 co-authors. Here are the top co-authors by number of shared publications:
- Appolinaire Djikeng
Infectious Diseases Group, The J. Craig Venter Institute (JCVI), Rockville, Maryland, United States of America
1 shared publication - Claudio L. Afonso
Southeast Poultry Research Laboratory, Agricultural Research Service, US Department of Agriculture, Athens, GA 30605, USA
1 shared publication - David Spiro
J. Craig Venter Institute, 9704 Medical Center Drive, Rockville, MD 20850, USA
1 shared publication - Elodie Ghedin
Division of Infectious Diseases, University of Pittsburgh School of Medicine, Pittsburgh, PA 15261, USA
1 shared publication - Jay DePasse
Division of Infectious Diseases, University of Pittsburgh School of Medicine, Pittsburgh, PA 15261, USA
1 shared publication - Jeremy I. Feldblyum
Department of Chemistry
1 shared publication
Latest Publications
- Open Access
- 1 February 2010
- Published by Oxford University Press (OUP) in Clinical Chemistry
- Vol. 56 (2) , 154-160
Adventures in Clinical Chemistry and Proteomics: A Personal Account
- 1 February 2010
- Published by Oxford University Press (OUP) in Clinical Chemistry
- Vol. 56 (2) , 154-160
Open AccessAdventures in Clinical Chemistry and Proteomics: A Personal Account
- Open Access
- 1 January 2008
- Published by Springer Nature in BMC Genomics
- Vol. 9 (1) , 5
Viral genome sequencing by random priming methods
Most emerging health threats are of zoonotic origin. For the overwhelming majority, their causative agents are RNA viruses which include but are not limited to HIV, Influenza, SARS, Ebola, Dengue, and Hantavirus. Of increasing importance therefore is a better understanding of global viral diversity to enable better surveillance and prediction of pandemic threats; this will require rapid and flexible methods for complete viral genome sequencing.
- 1 January 2008
- Published by Springer Nature in BMC Genomics
- Vol. 9 (1) , 5
Open AccessViral genome sequencing by random priming methods
Most emerging health threats are of zoonotic origin. For the overwhelming majority, their causative agents are RNA viruses which include but are not limited to HIV, Influenza, SARS, Ebola, Dengue, and Hantavirus. Of increasing importance therefore is a better understanding of global viral diversity to enable better surveillance and prediction of pandemic threats; this will require rapid and flexible methods for complete viral genome sequencing.
- Open Access
- 1 July 2003
- Published by Centers for Disease Control and Prevention (CDC) in Emerging Infectious Diseases
- Vol. 9 (7) , 768-773
Global Screening for Human Viral Pathogens
We propose a system for continuing surveillance of viral pathogens circulating in large human populations. We base this system on the physical isolation of viruses from large pooled samples of human serum and plasma (e.g., discarded specimens from diagnostic laboratories), followed by shotgun sequencing of the resulting genomes. The technology for concentrating virions from 100-L volumes was developed previously at Oak Ridge National Laboratory, and the means for purifying and concentrating virions from volumes in microliters have been developed recently. At the same time, marine virologists have developed efficient methods for concentrating, amplifying, and sequencing complex viral mixtures obtained from the ocean. Given this existing technology base, we believe an integrated, automated, and contained system for surveillance of the human “virome” can be implemented within 1 to 2 years. Such a system could monitor the levels of known viruses in human populations, rapidly detect outbreaks, and systematically discover novel or variant human viruses.
- 1 July 2003
- Published by Centers for Disease Control and Prevention (CDC) in Emerging Infectious Diseases
- Vol. 9 (7) , 768-773
Open AccessGlobal Screening for Human Viral Pathogens
We propose a system for continuing surveillance of viral pathogens circulating in large human populations. We base this system on the physical isolation of viruses from large pooled samples of human serum and plasma (e.g., discarded specimens from diagnostic laboratories), followed by shotgun sequencing of the resulting genomes. The technology for concentrating virions from 100-L volumes was developed previously at Oak Ridge National Laboratory, and the means for purifying and concentrating virions from volumes in microliters have been developed recently. At the same time, marine virologists have developed efficient methods for concentrating, amplifying, and sequencing complex viral mixtures obtained from the ocean. Given this existing technology base, we believe an integrated, automated, and contained system for surveillance of the human “virome” can be implemented within 1 to 2 years. Such a system could monitor the levels of known viruses in human populations, rapidly detect outbreaks, and systematically discover novel or variant human viruses.